If you have not already registered for Full Text Access to The Journal, then visit our registration page.

VOLUME 68   2007   NUMBER 11

Editorial

1638 Early Career Psychiatrists Section. Marlene P. Freeman
[PDF]

Original Articles

1639 Virtual Reality Exposure Therapy for the Treatment of Posttraumatic Stress Disorder Following September 11, 2001. JoAnn Difede, Judith Cukor, Nimali Jayasinghe, Ivy Patt, Sharon Jedel, Lisa Spielman, Cezar Giosan, and Hunter G. Hoffman
[Abstract] [PDF]

1648 Vitamin B6 Treatment for Tardive Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. Vladimir Lerner, Chanoch Miodownik, Alexander Kaptsan, Yuly Bersudsky, Igor Libov, Ben-Ami Sela, and Eliezer Witztum
[Abstract] [PDF]

1655 Diagnosing Co-Occurring Substance-Related Disorders: Agreement Between SCID, Hispanic Clinicians, and Non-Hispanic Clinicians. Luis R. Torres, Luis H. Zayas, Leopoldo J. Cabassa, and M. Carmela Prez
[Abstract] [PDF]

1663 A Randomized, Double-Blind, Placebo-Controlled Trial of Desvenlafaxine Succinate in Adult Outpatients With Major Depressive Disorder. Michael R. Liebowitz, Paul P. Yeung, and Richard Entsuah
[Abstract] [PDF]

1673 A Comparison of Selected Risk Factors for Unipolar Depressive Disorder, Bipolar Affective Disorder, Schizoaffective Disorder, and Schizophrenia From a Danish Population-Based Cohort. Thomas Munk Laursen, Trine Munk-Olsen, Merete Nordentoft, and Preben Bo Mortensen
[Abstract] [PDF]

1682 Blood Glucose and Schizophrenia: A Systematic Review of Prospective Randomized Clinical Trials. Chris J. Bushe and Brian E. Leonard
[Abstract] [PDF]

1691 Gabapentin Reduces Alcohol Consumption and Craving: A Randomized, Double-Blind, Placebo-Controlled Trial. Fernando A. Furieri and Ester M. Nakamura-Palacios
[Abstract] [PDF]

1701 Antidepressant Medication Treatment Failure Does Not Predict Lower Remission With ECT for Major Depressive Disorder: A Report From the Consortium for Research in Electroconvulsive Therapy. Keith G. Rasmussen, Martina Mueller, Rebecca G. Knapp, Mustafa M. Husain, Teresa A. Rummans, Shirlene M. Sampson, M. Kevin O'Connor, Georgios Petrides, Max Fink, and Charles H. Kellner
[Abstract] [PDF]

1707 Efficacy and Safety of Duloxetine 60 mg Once Daily in the Treatment of Pain in Patients With Major Depressive Disorder and At Least Moderate Pain of Unknown Etiology: A Randomized Controlled Trial. Stephan Brecht, Christine Courtecuisse, Catherine Debieuvre, Jens Croenlein, Durisala Desaiah, Joel Raskin, Claude Petit, and Koen Demyttenaere
[Abstract] [PDF]

1717 Clinical Characteristics and Psychiatric Comorbidity of Pyromania. Jon E. Grant and Suck Won Kim
[Abstract] [PDF]

1723 Improvement in Subjective Sleep in Major Depressive Disorder With a Novel Antidepressant, Agomelatine: Randomized, Double-Blind Comparison With Venlafaxine. Patrick Lemoine, Christian Guilleminault, and Enric Alvarez
[Abstract] [PDF]

1733 A 12-Week Randomized Clinical Trial to Evaluate Metabolic Changes in Drug-Naive, First-Episode Psychosis Patients Treated With Haloperidol, Olanzapine, or Risperidone. Rocio Perez-Iglesias, Benedicto Crespo-Facorro, Jose Antonio Amado, Maria Teresa Garcia-Unzueta, Maria Luz Ramirez-Bonilla, Cesar Gonzalez-Blanch, Obdulia Martinez-Garcia, and Jose Luis Vazquez-Barquero
[Abstract] [PDF]

1741 Suicidal Behavior in Obsessive-Compulsive Disorder. Prakash Kamath, Y. C. Janardhan Reddy, and Thennarasu Kandavel
[Abstract] [PDF]

1751 The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2006 Update. Troy A. Moore, Robert W. Buchanan, Peter F. Buckley, John A. Chiles, Robert R. Conley, M. Lynn Crismon, Susan M. Essock, Molly Finnerty, Stephen R. Marder, Del D. Miller, Joseph P. McEvoy, Delbert G. Robinson, Nina R. Schooler, Steven P. Shon, T. Scott Stroup, and Alexander L. Miller
[Abstract] [PDF]

1763 Maintenance Treatment With Risperidone or Low-Dose Haloperidol in First-Episode Schizophrenia: 1-Year Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia. Wolfgang Gaebel, Mathias Riesbeck, Wolfgang Wlwer, Ansgar Klimke, Matthias Eickhoff, Martina von Wilmsdorff, Maria C. Jockers-Scherbl, Kai-Uwe Khn, Matthias Lemke, Andreas Bechdolf, Stefan Bender, Detlef Degner, Ralf Schlsser, Lutz G. Schmidt, Andrea Schmitt, Markus Jger, Gerd Buchkremer, Peter Falkai, Stefan Klingberg, Wolfgang Kpcke, Wolfgang Maier, Heinz Hfner, Christian Ohmann, Hans J. Salize, Frank Schneider, and Hans-Jrgen Mller, for the German Study Group on First-Episode Schizophrenia
[Abstract] [PDF]

Early Career psychiatrists

1775 Early Careers and New Data. Marlene P. Freeman
[PDF]

1776 A Systematic Review of Rates and Diagnostic Validity of Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder. Aliza P. Wingo and S. Nassir Ghaemi
[Abstract] [PDF]

1785 Comparison of Antidepressant Use Between Subjects With Bipolar Disorder and Major Depressive Disorder With or Without Comorbid Anxiety. Ayal Schaffer, John Cairney, Scott Veldhuizen, Amy Cheung, and Anthony Levitt
[Abstract] [PDF]

1793 Effect of Olanzapine, Risperidone, and Haloperidol Treatment on Weight and Body Mass Index in First-Episode Schizophrenia Patients in India: A Randomized, Double-Blind, Controlled, Prospective Study. Sahoo Saddichha, Narayana Manjunatha, Shahul Ameen, and Sayeed Akhtar
[Abstract] [PDF]

Academic Highlights

1799 The Roadmap for Antipsychotic Psychopharmacology: An Overview. [CME]
[PDF]

ASCP Corner

1807 Teaching and Practicing Psychopharmacology. John M. Kane
[PDF]

A Psychiatrist's Diary

1809 Are You Analyzing Me? Shyam K. Bhat
[PDF]

Letters TO the Editor   [PDF]

1811 Response to Self-Injurious Behaviors in a Community Sample of Young Women. Paul L. Plener and Efrosini Kokaliari

Reply by Angela Favaro, Silvia Ferrara, and Paolo Santonastaso

1812 Aripiprazole and Perphenazine: No Difference. Robert A. Rosenheck

Reply by John M. Kane, Herbert Y. Meltzer, William H. Carson, Jr., Robert D. McQuade, Ronald N. Marcus, and Raymond Sanchez

1814 A Case of Aripiprazole-Related Tardive Akathisia and Its Treatment With Ropinirole. John M. Hettema and David E. Ross

1815 Aripiprazole Treatment of Patients With Borderline Personality Disorder. Marius K. Nickel

Book Reviews 1817    [PDF]

Electronic CME Activities

Available through www.psychiatrist.com/toc

e26 Recognition and Treatment of Panic Disorder. R. Bruce Lydiard

e27 A Clinician's View of the Data on Bipolar Disorder. Noel C. Gardner

e28 The Effect of Stimulant Treatment for ADHD on Later Substance Abuse and the Potential for Medication Misuse, Abuse, and Diversion. Stephen V. Faraone and Himanshu P. Upadhyaya